Cardiomyopathies: Clinical Trials

1,376 trials for Cardiomyopathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

616 completed, 261 unknown, 244 recruiting, 69 terminated. 316 Not applicable, 174 Phase 2, 108 Phase 3, 101 Phase 1, 66 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable316Completed 144, Unknown 64, Recruiting 38, Terminated 24, Not yet recruiting 16, Active not recruiting 15, Withdrawn 12, Suspended 2, Enrolling by invitation 1
Phase 2174Completed 100, Recruiting 25, Unknown 19, Terminated 15, Active not recruiting 7, Withdrawn 4, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 3108Completed 54, Unknown 15, Recruiting 14, Terminated 9, Active not recruiting 8, Not yet recruiting 4, Enrolling by invitation 2, Withdrawn 2
Phase 1101Completed 55, Recruiting 18, Unknown 10, Terminated 7, Withdrawn 4, Not yet recruiting 3, Active not recruiting 2, Suspended 2
Phase 466Completed 34, Unknown 12, Recruiting 10, Active not recruiting 3, Terminated 3, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Early Phase 16Completed 4, Not yet recruiting 1, Unknown 1

Follow Cardiomyopathies: new trials by email Literature Review of Cardiomyopathies trials Research Report on Cardiomyopathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aficamten and Patient-Reported Outcomes in Real-World nHCM
receiving aficamten - Hypertrophic Cardiomyopathy (HCM)
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002027-06-012026-09-29
Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy
Melatonin 10 MG, Selenium, Placebo - Ppm, Cardiomyopathy
Not applicableNot yet recruitingTanta University252026-12-202026-01-12
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Clinical Decision Aid, Standard Care - Heart Failure, Coronary Artery Disease
Not yet recruitingMedical College of Wisconsin602026-12-012025-10-14
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
Beta-Blocker Sequential Tapering and Discontinuation, Beta-Blocker Baseline Stable-Dose Maintenance - Obstructive Hypertrophic Cardiomyopathy (oHCM)
Not applicableNot yet recruitingFirst Affiliated Hospital of Wenzhou Medical University2862026-12-012026-09-11
BAG3-DCM Natural History Study
Dilated Cardiomyopathy (DCM), Cardiovascular Diseases
Not yet recruitingRocket Pharmaceuticals Inc.302026-12-012026-10-19
Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure
Pulmonary Vein Isolation, Pharmacological Rate Control - Heart Failure With Reduced Ejection Fraction, Atrial Fibrillation (AF)
Phase 3Not yet recruitingUniversity of British Columbia10502026-11-012026-10-14
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Acoramidis (AG10) - Amyloidosis in Transthyretin (TTR), Amyloidosis, Familial
Phase 3Not yet recruitingEidos Therapeutics, a BridgeBio company2502026-11-012026-08-11
Cardiac Imaging in Systemic Disorders: the ORACLES Registry
data collection - Lupus
Not yet recruitingAssistance Publique - Hôpitaux de Paris15002026-11-012026-02-13
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
SESAME Procedure - Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)2002026-10-272026-10-22
Human Experimental Models of Pain (HEMP)
Placebo, Naproxen, Pregabalin - Acute Pain
Not applicableNot yet recruitingNational Center for Complementary and Integrative Health (NCCIH)252026-10-272026-10-22
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults
ATI-105, Placebo - Friedreich Ataxia, Cardiomyopathies
Phase 1Not yet recruitingAdjuvia Therapeutics, Inc.602026-10-262026-10-09
Aom0304 in Adult Patients With Symptomatic Hypertrophic Cardiomyopathy
QG101-23-0 enteric coated capsule (60/120/240/360 mg BID), QG101-23-0 enteric coated capsule (120/240/360/480mg BID) - Hypertrophic Cardiomyopathy (HCM), Obstructive HCM (oHCM)
Phase 2Not yet recruitingAmckaus PTY LTD.562026-10-012026-06-30
Echocardiographic Perspectives on Transient Mitral Regurgitation After Septal Myectomy
Hypertrophic Cardiomyopathy
Not yet recruitingUniversity Health Network, Toronto1502026-10-012026-10-14
Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy
Coronary sinus reducer, Placebo procedure - Hypertrophic Cardiomyopathy
Not applicableNot yet recruitingImperial College London502026-10-012026-10-08
Procedural Endpoint in Left Bundle Branch Area Pacing: Conduction System Capture Versus LV Septal Capture
LBBAP with mandatory left ventricular conduction system capture (LBBP or LFP), LBBAP with left ventricular septal capture as the accepted procedural endpoint (LVSP) - Bradycardia, Atrioventricular Block
Not applicableNot yet recruitingYonsei University3002026-10-012026-09-04
Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications
Type 2 Diabetes Mellitus, Cardiovascular Diseases
Not yet recruitingAssiut University852026-10-012026-09-29
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
AFTX-201 - Dilated Cardiomyopathy (DCM), BAG3 Mutation Associated Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingAffinia Therapeutics222026-10-012026-10-21
Nutritional Assessment in Children With Cardiomyopathy
Cardiomyopathies, Malnutrition
Not yet recruitingAssiut University1082026-09-302026-10-05
Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy
Mavacamten - Obstructive Hypertrophic Cardiomyopathy (oHCM)
Not yet recruitingBristol-Myers Squibb8002026-09-302026-09-29
Spectroscopic Assessment of Myocardial Oxygenation Changes in Pediatric Heart Surgery
Myocardial Ischemia, Heart Defects, Congenital
RecruitingSpectrocor302026-09-172026-09-28

Showing 20 of 1376. Sign in to see all of them.

Narrower conditions

Cardiomyopathy, Hypertrophic (352)  ·  Heart Failure (296)  ·  Cardiomyopathy, Dilated (242)  ·  Myocarditis (152)  ·  Heart Diseases (77)  ·  Cardiovascular Diseases (76)  ·  Takotsubo Cardiomyopathy (63)  ·  Arrhythmias, Cardiac (61)  ·  Myocardial Reperfusion Injury (56)  ·  Death, Sudden, Cardiac (52)  ·  Myocardial Infarction (51)  ·  Arrhythmogenic Right Ventricular Dysplasia (47)  ·  Coronary Artery Disease (43)  ·  Amyloidosis (37)

Broader conditions

Cardiovascular Diseases (1300)  ·  Heart Diseases (1299)  ·  Pathological Conditions, Signs and Symptoms (440)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (406)  ·  Pathologic Processes (364)  ·  Heart Valve Diseases (363)  ·  Aortic Valve Disease (357)  ·  Aortic Stenosis, Subvalvular (353)  ·  Aortic Valve Stenosis (348)  ·  Genetic Diseases, Inborn (344)  ·  Cardiomegaly (263)  ·  Vascular Diseases (245)  ·  Laminopathies (238)  ·  Nutritional and Metabolic Diseases (147)

Interventions

MYK-461 (37)  ·  Echocardiography (25)  ·  Blood Specimen Collection (14)  ·  Exercise (13)  ·  Electrocardiography (12)  ·  Metoprolol (12)  ·  Natriuretic Peptide, Brain (10)  ·  Standard of Care (9)  ·  Cardiac Resynchronization Therapy (8)  ·  Carvedilol (8)  ·  Magnetic Resonance Spectroscopy (8)  ·  Perhexiline (8)  ·  empagliflozin (8)  ·  Bisoprolol (7)  ·  Defibrillators, Implantable (7)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (37)  ·  Bristol-Myers Squibb (28)  ·  Mayo Clinic (27)  ·  Assistance Publique - Hôpitaux de Paris (22)  ·  Xijing Hospital (16)  ·  Imperial College London (14)  ·  Assiut University (13)  ·  China National Center for Cardiovascular Diseases (12)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (11)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (11)  ·  Emory University (10)  ·  Abbott Medical Devices (9)  ·  Alnylam Pharmaceuticals (9)  ·  Duke University (9)  ·  Pfizer (9)

Countries

United States (447)  ·  United Kingdom (142)  ·  France (134)  ·  China (123)  ·  Germany (123)  ·  Italy (108)  ·  Canada (88)  ·  Spain (70)  ·  Netherlands (58)  ·  Denmark (44)  ·  Poland (44)  ·  Brazil (41)  ·  Sweden (39)  ·  Belgium (35)  ·  Austria (32)

Top investigators

Paolo Della Bella, MD (5)  ·  Barry Greenberg, MD (4)  ·  Michael Zapien, MS, CCRA (4)  ·  Yang Yan (4)  ·  Dao Wen Wang, Doctor (3)  ·  Dhanunjaya Lakkireddy, MD (3)  ·  James Ware (3)  ·  Jared Gollob, MD (3)  ·  Sarah Thordsen, MD (3)

Results publications

PMID 37979797, PMID 42636950, PMID 36718638, PMID 38979608, PMID 40739200, PMID 10400005, PMID 16928995, PMID 17582361, PMID 21087331, PMID 21505058, PMID 22651868, PMID 22936827, PMID 23362308, PMID 24414062, PMID 24621999, PMID 24750460, PMID 25142002, PMID 25176015, PMID 25533774, PMID 26680013, PMID 28306757, PMID 28912187, PMID 28917683, PMID 29447739, PMID 30077990, PMID 30360992, PMID 31642911, PMID 32871100, PMID 33574022, PMID 34081217, PMID 34525837, PMID 35861811, PMID 36404406, PMID 36456068, PMID 36652223, PMID 37010012, PMID 37480391, PMID 38722325, PMID 39213194, PMID 39217450, PMID 39302117, PMID 39855458, PMID 41903627, PMID 42307907, PMID 42389794, PMID 42624353, PMID 42669063, PMID 42669065, PMID 7994859, PMID 10368877

NIH funding

2019 (12), 2023 (6), 2015 (5), 2025 (5), 2004 (2), 2009 (2), 2016 (2), 2017 (2), 2018 (2), U01HL088942 (2), 1RC1LM010526 (1), 2014 (1), 3UM1AI068614-14S1 (1), 5UM1HL087318 (1), K12AR084222 (1)